California Public Employees Retirement System’s Myriad Genetics MYGN Stock Holding History

California Public Employees Retirement System’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-145,900	Closed	-$4.44M	–	2410
2021 Q1	$4.44M	Sell	145,900 -13,446	-8%	-$382K	﹤0.01%	1506
2020 Q4	$3.15M	Sell	159,346 -3,000	-2%	-$48.4K	﹤0.01%	1706
2020 Q3	$2.12M	Buy	162,346 +4,800	+3%	+$60.7K	﹤0.01%	1800
2020 Q2	$1.79M	Sell	157,546 -900	-0.6%	-$12.8K	﹤0.01%	1858
2020 Q1	$2.27M	Sell	158,446 -22,700	-13%	-$480K	﹤0.01%	1533
2019 Q4	$4.93M	Buy	181,146 +10,561	+6%	+$291K	﹤0.01%	1467
2019 Q3	$4.88M	Buy	170,585 +27,970	+20%	+$815K	﹤0.01%	1322
2019 Q2	$3.96M	Sell	142,615 -18,767	-12%	-$530K	﹤0.01%	1262
2019 Q1	$5.36M	Sell	161,382 -3,302	-2%	-$101K	0.01%	1126
2018 Q4	$4.79M	Sell	164,684 -16,074	-9%	-$578K	0.01%	1147
2018 Q3	$8.31M	Buy	180,758 +14,205	+9%	+$632K	0.01%	987
2018 Q2	$6.22M	Sell	166,553 -105,372	-39%	-$3.56M	0.01%	1175
2018 Q1	$8.04M	Sell	271,925 -46,692	-15%	-$1.58M	0.01%	1016
2017 Q4	$10.9M	Buy	318,617 +33,337	+12%	+$1.12M	0.01%	869
2017 Q3	$10.3M	Buy	285,280 +10,280	+4%	+$293K	0.02%	853
2017 Q2	$7.11M	Buy	275,000 +17,100	+7%	+$363K	0.01%	1034
2017 Q1	$4.95M	Buy	257,900 +18,400	+8%	+$326K	0.01%	1281
2016 Q4	$3.99M	Sell	239,500 -25,700	-10%	-$465K	0.01%	1438
2016 Q3	$5.46M	Sell	265,200 -17,200	-6%	-$436K	0.01%	1234
2016 Q2	$8.64M	Sell	282,400 -8,400	-3%	-$292K	0.01%	913
2016 Q1	$10.9M	Sell	290,800 -16,800	-5%	-$633K	0.02%	797
2015 Q4	$13.3M	Buy	307,600 +13,400	+5%	+$566K	0.02%	711
2015 Q3	$11M	Hold	294,200	–	–	0.02%	794
2015 Q2	$10M	Sell	294,200 -10,400	-3%	-$354K	0.02%	911
2015 Q1	$11.5M	Hold	304,600	–	–	0.02%	864
2014 Q4	$11.5M	Buy	304,600 +10,400	+4%	+$369K	0.02%	864
2014 Q3	$11.3M	Sell	294,200 -230,230	-44%	-$8.59M	0.02%	882
2014 Q2	$20.4M	Sell	524,430 -67,210	-11%	-$2.5M	0.03%	627
2014 Q1	$23.9M	Buy	591,640 +26,240	+5%	+$813K	0.03%	540
2013 Q4	$13.7M	Buy	565,400 +312,448	+124%	+$7.9M	0.02%	779
2013 Q3	$5.94M	Buy	252,952 +31,400	+14%	+$892K	0.01%	1130
2013 Q2	$5.95M	Buy	+221,552	New	+$6.42M	0.01%	1020

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

California Public Employees Retirement System's MYGN Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Myriad Genetics (MYGN) in Q2 2021, closing a stake of 145,900 shares — an estimated $4.44M sold.

California Public Employees Retirement System first reported a position in MYGN in Q2 2013 and held it in 32 quarters. The position peaked at $23.9M in Q1 2014. 201 funds tracked by Wall St. Rank hold MYGN as of Q2 2021.

California Public Employees Retirement System reported no remaining Myriad Genetics position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 145,900 Myriad Genetics shares in Q2 2021, an estimated $4.44M.
California Public Employees Retirement System first reported a position in Myriad Genetics in Q2 2013 and held it in 32 quarters.
California Public Employees Retirement System's Myriad Genetics position peaked at $23.9M in Q1 2014.
201 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.